Abstract:Following the publication of the above article, a concerned reader drew to the Editor's attention that the Transwell cell invasion assay data featured in Figs. 3 and 5, and the cell microscopic/morphological images shown in Fig. 4A and C, were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes that had either already been published elsewhere prior to the submission of this paper to Oncology Reports , or which under consideration for publication at around the same time (several of which have now been retracted). In addition, overlapping sections of data were noted within Figs. 3 and 5, such that data which were intended to represent the results from differently performed experiments had apparently been derived from the same original source(s). In view of the fact that certain of these data had already apparently been published prior to the submission of this article for publication, the Editor of Oncology Reports has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they agreed with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 36: 3105‐3112, 2016; DOI: 10.3892/or.2016.5146]

[Retracted] Effects of Grb2‐associated binding protein 2‐specific siRNA on the migration and invasion of MG‐63 osteosarcoma cells

[Retracted] SOX2 knockdown inhibits the migration and invasion of basal cell carcinoma cells by targeting the SRPK1‐mediated PI3K/AKT signaling pathway

[Retracted] miR‐133b induces chemoresistance of osteosarcoma cells to cisplatin treatment by promoting cell death, migration and invasion

[Retracted] miR‐17‐5p promotes the growth of osteosarcoma in a BRCC2‐dependent mechanism

[Retracted] miR‐34a is downregulated in human osteosarcoma stem‐like cells and promotes invasion, tumorigenic ability and self‐renewal capacity

[Retracted] SRC‐like adaptor protein negatively regulates Wnt signaling in intrahepatic cholangiocarcinoma

[Retracted] MicroRNA‑874 Inhibits Growth, Induces Apoptosis and Reverses Chemoresistance in Colorectal Cancer by Targeting X‑linked Inhibitor of Apoptosis Protein

[Retracted] CXCL5 promotes the proliferation and migration of glioma cells in autocrine‑ and paracrine‑dependent manners

[Retracted] Schisandrin B inhibits epithelial‐mesenchymal transition and stemness of large‐cell lung cancer cells and tumorigenesis in xenografts via inhibiting the NF‐κB and p38 MAPK signaling pathways

[Retracted] Long non‐coding RNA Igf2as controls hepatocellular carcinoma progression through the ERK/MAPK signaling pathway

[Retracted] MicroRNA‑132 inhibits cell growth and metastasis in osteosarcoma cell lines possibly by targeting Sox4

[Retracted] Silencing of RTKN2 by siRNA suppresses proliferation, and induces G1 arrest and apoptosis in human bladder cancer cells

[Retracted] LncRNA GAS6 antisense RNA 1 facilitates the tumorigenesis of clear cell renal cell carcinoma by regulating the AMP‐activated protein kinase/mTOR signaling pathway

[Retracted] MicroRNA‐329‐3p targets MAPK1 to suppress cell proliferation, migration and invasion in cervical cancer

[Retracted] Effect of RhoC on the epithelial‐mesenchymal transition process induced by TGF‐β1 in lung adenocarcinoma cells

[Retracted] Targeting of TLE3 by miR‐3677 in human breast cancer promotes cell proliferation, migration and invasion

[Retracted] Activation of the LKB1‐SIK1 signaling pathway inhibits the TGF‐β‐mediated epithelial‐mesenchymal transition and apoptosis resistance of ovarian carcinoma cells

Retraction: Cxcl5 Promotes The Proliferation And Migration Of Glioma Cells In Autocrine- And Paracrine-Dependent Manners (Retraction Of Vol 36, Pg 3303, 2016)

[Retracted] The oncogenic roles of 27‐hydroxycholesterol in glioblastoma

[Retracted] p68 prompts the epithelial‐mesenchymal transition in cervical cancer cells by transcriptionally activating the TGF‐β1 signaling pathway

[Retracted] hsa‐miR‐212 modulates the radiosensitivity of glioma cells by targeting BRCA1